Bausch Health Cos EBIT 2010-2024 | BHC

Bausch Health Cos ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.
Bausch Health Cos Annual EBIT
(Millions of US $)
2023 $963
2022 $454
2021 $450
2020 $676
2019 $-203
2018 $-2,384
2017 $102
2016 $-566
2015 $1,527
2014 $2,001
2013 $-410
2012 $80
2011 $300
2010 $-110
2009 $181
Bausch Health Cos Quarterly EBIT
(Millions of US $)
2024-09-30 $318
2024-06-30 $389
2024-03-31 $281
2023-12-31 $362
2023-09-30 $14
2023-06-30 $412
2023-03-31 $175
2022-12-31 $-244
2022-09-30 $244
2022-06-30 $161
2022-03-31 $293
2021-12-31 $367
2021-09-30 $574
2021-06-30 $-270
2021-03-31 $-221
2020-12-31 $-5
2020-09-30 $460
2020-06-30 $-27
2020-03-31 $248
2019-12-31 $-1,076
2019-09-30 $329
2019-06-30 $257
2019-03-31 $287
2018-12-31 $25
2018-09-30 $117
2018-06-30 $-245
2018-03-31 $-2,281
2017-12-31 $-322
2017-09-30 $38
2017-06-30 $175
2017-03-31 $211
2016-12-31 $150
2016-09-30 $-863
2016-06-30 $81
2016-03-31 $66
2015-12-31 $167
2015-09-30 $448
2015-06-30 $342
2015-03-31 $571
2014-12-31 $605
2014-09-30 $684
2014-06-30 $355
2014-03-31 $357
2013-12-31 $224
2013-09-30 $-892
2013-06-30 $142
2013-03-31 $117
2012-12-31 $-98
2012-09-30 $29
2012-06-30 $87
2012-03-31 $61
2011-12-31 $-6
2011-09-30 $112
2011-06-30 $118
2011-03-31 $75
2010-12-31 $-49
2010-09-30 $-126
2010-06-30 $49
2010-03-31 $16
2009-12-31 $59
2009-09-30 $58
2009-06-30 $11
2009-03-31 $54
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.439B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.679B 6.46
Dr Reddy's Laboratories (RDY) India $12.521B 23.96
BridgeBio Pharma (BBIO) United States $4.911B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.335B 14.04
Supernus Pharmaceuticals (SUPN) United States $2.022B 27.53
Taysha Gene Therapies (TSHA) United States $0.334B 54.33
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00